A new AI-powered technique can now monitor blood clot formation in real time—offering cardiologists personalized insight into antiplatelet drug effectiveness, according to a study in Nature Communications.
Researchers used a high-speed microscope paired with AI algorithms to analyze blood from over 200 patients with coronary artery disease (CAD). The AI detected clotting risk before clots formed, offering doctors a powerful tool to optimize treatment.
Key breakthroughs:
- Personalized therapy: The AI tracks how individual patients respond to antiplatelet drugs.
- Non-invasive sampling: Blood from the arm, not arteries, was enough to assess clot risk.
- Improved safety: Enables proactive treatment adjustments to avoid bleeding or thrombosis.
While further research is needed, this innovation marks a step toward real-time, precision cardiovascular care.
Follow MEDWIRE.AI for the latest in cardiovascular AI advancements.
